Pheochromocytoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pheochromocytoma}} | {{Pheochromocytoma}} | ||
{{CMG}} | {{CMG}}{{AE}} {{MAD}} | ||
==Overview== | ==Overview== | ||
| Line 10: | Line 10: | ||
* Preoperative treatment of pheochromocytoma is the best way to reduce complications and improve morbidity by controlling hypertension during surgery and [[hypotension]] after it. | * Preoperative treatment of pheochromocytoma is the best way to reduce complications and improve morbidity by controlling hypertension during surgery and [[hypotension]] after it. | ||
*All patients with | *All patients with pheochromocytoma need postoperative follow up:<ref name="pmid15644401">{{cite journal| author=Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF| title=Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. | journal=J Clin Endocrinol Metab | year= 2005 | volume= 90 | issue= 4 | pages= 2110-6 | pmid=15644401 | doi=10.1210/jc.2004-1398 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15644401 }}</ref> | ||
**Patients should undergo baseline postoperative biochemical testing and annual lifelong tests.<ref name="pmid15080378">{{cite journal| author=Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T| title=Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. | journal=Hypertens Res | year= 2004 | volume= 27 | issue= 3 | pages= 193-202 | pmid=15080378 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15080378 }}</ref> | **Patients should undergo baseline postoperative biochemical testing and annual lifelong tests.<ref name="pmid15080378">{{cite journal| author=Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T| title=Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. | journal=Hypertens Res | year= 2004 | volume= 27 | issue= 3 | pages= 193-202 | pmid=15080378 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15080378 }}</ref> | ||
** | **the noncatecholamine-producing tumor should undergo annual imaging with CT or MRI to monitor for recurrence.<ref name="pmid150803782">{{cite journal| author=Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T| title=Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. | journal=Hypertens Res | year= 2004 | volume= 27 | issue= 3 | pages= 193-202 | pmid=15080378 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15080378 }}</ref> | ||
*Genetic testing should be performed in:<sup>[[Pheochromocytoma screening#cite note-pmid24893135-2|[2]]]</sup> | *Genetic testing should be performed in:<sup>[[Pheochromocytoma screening#cite note-pmid24893135-2|[2]]]</sup> | ||
**Patients with a family history of pheochromocytoma | **Patients with a family history of pheochromocytoma | ||
Revision as of 13:27, 21 July 2017
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma secondary prevention |
|
Risk calculators and risk factors for Pheochromocytoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
Overview
Preoperative treatment of pheochromocytoma is the best way to reduce complications and postoperative follow up is the besy way to reduce recurrence.
Secondary Prevention
- Recurrence is lower than 10%[1]
- Preoperative treatment of pheochromocytoma is the best way to reduce complications and improve morbidity by controlling hypertension during surgery and hypotension after it.
- All patients with pheochromocytoma need postoperative follow up:[2]
- Genetic testing should be performed in:[2]
- Patients with a family history of pheochromocytoma
- Bilateral or multifocal lesions
- Tumors or malignant or extra-adrenal pheochromocytoma
- Young patients who are aged 50 years or under
References
- ↑ Hu K, Persky MS (2003). "Multidisciplinary management of paragangliomas of the head and neck, Part 1". Oncology (Williston Park). 17 (7): 983–93. PMID 12886866.
- ↑ Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF (2005). "Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma". J Clin Endocrinol Metab. 90 (4): 2110–6. doi:10.1210/jc.2004-1398. PMID 15644401.
- ↑ Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004). "Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan". Hypertens Res. 27 (3): 193–202. PMID 15080378.
- ↑ Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004). "Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan". Hypertens Res. 27 (3): 193–202. PMID 15080378.